Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

METHODS: Ovid MEDLINE, Embase, CINAHL, and Cochrane CENTRAL databases were
searched for manuscripts and conference abstracts published between 2011 and 2021 …

Background & aims Novel, effective treatments for Helicobacter pylori infection are needed.
This study evaluated the efficacy of vonoprazan, a potassium-competitive acid blocker, vs …

Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …

We provide a primer to assist in the difficult transition of Helicobacter pylori therapy
guidelines to those that adhere to the principles of antimicrobial stewardship. This transition …

Helicobacter pylori gastritis is now recognized as an important transmissible infectious
disease involving the stomach (1). Increasing rates of antimicrobial resistance worldwide …

Helicobacter pylori infection causes chronic gastritis, which can progress to severe
gastroduodenal pathologies, including peptic ulcer, gastric cancer and gastric mucosa …

The increasing rates of antibiotic resistance in Helicobacter pylori (H. pylori) are a major
concern of the decreasing eradication rate. Large-scale and long-period studies on …

Background & Aims The decline in Helicobacter pylori cure rates emphasizes the need for
readily available methods to determine antimicrobial susceptibility. Our aim was to compare …

Helicobacter pylori is the most common chronic bacterial infection worldwide and the most
significant risk factor for gastric cancer, which remains a leading cause of cancer-related …